semaglutide gastroparesis class action in west virginia KFF Health News Hims & Hers class action

" Journal of Khyber College of Dentistry 1.02 (2011): 95-99

About half of GLP-1 users say these drugs were difficult for them to afford, according to KFF polling

This is just one of the many potential benefits that this drug has been associated with, and more doctors are prescribing Semaglutide for weight loss purposes today

Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance." In several clinical trials, carriers were significantly less likely to reach healthy blood sugar targets while taking GLP-1 medications

For researchers and clinicians following this issue, this is the central question in the upcoming FDA decision: is dysesthesia frequent and debilitating enough to justify a special mention in the indications, or even a 12 mg dose reserved for specific patients